DE MARIA, ANDREA
 Distribuzione geografica
Continente #
EU - Europa 22.347
Totale 22.347
Nazione #
IT - Italia 22.347
Totale 22.347
Città #
Genova 17.977
Rapallo 2.673
Genoa 1.653
Bordighera 44
Totale 22.347
Nome #
The Ligurian Human Immunodeficiency Virus Clinical Network: A Web Tool to Manage Patients With Human Immunodeficiency Virus in Primary Care and Multicenter Clinical Trials 180
Are there Gender and Race Differences in cellular immunity patterns over age in infected and uninfected children born to HIV-1 infected women? 148
Factors associated with HIV RNA levels in pregnant women on non-suppressive highly active antiretroviral therapy at conception 148
Il sistema TIDA nell'emicrania: effetto della nomifensina sulla secrezione di prolattina 146
Human NK cell receptors/markers: A tool to analyze NK cell development, subsets and function. 144
Impaired response to influenza vaccine associated with persistent memory B cell depletion in non-Hodgkin's lymphoma patients treated with rituximab-containing regimens. 142
Early versus late treatment with Zidovudine 139
Natural killer cells in HIV controller patients express an activated effector phenotype and do not up-regulate NKp44 on IL-2 stimulation. 134
Functionally relevant decreases in activatory receptor expression on NK cells are associated with pulmonary tuberculosis in vivo and persist after successful treatment. 130
Seasonal and pandemic (A/H1N1 2009) MF-59-adjuvanted influenza vaccines in complete remission non-Hodgkin lymphoma patients previously treated with rituximab containing regimens. 130
Clinical characteristics, management and in-hospital mortality of patients with COVID-19 In Genoa, Italy 130
Pregnancy and neonatal outcomes among a cohort of HIV-infected women in a large Italian teaching hospital: a 30-year retrospective study 128
Expression of HLA-class I-specific inhibitory Natural Killer cell receptors in HIV-specific cytolytic T lymphocytes. Impairment of specific cytolytic functions. 126
The HLA class II transcriptional activator blocks the function of HIV-1 Tat and inhibits viral replication. 126
HCV-related polyradiculoneuropathy in a HIV-positive man 126
Analysis of clinical management of infected breast implants and of factors associated to successful breast pocket salvage in infections occurring after breast reconstruction 126
Use of Neonatal Antiretroviral Prophylaxis for Prevention of Mother‐to‐Child Transmission of HIV Is Decreasing in Western Europe 125
Are girls more at risk of intrauterine-acquired HIV infection than boys? 125
Increased natural cytotoxicity receptor expression and relevant IL-10 production in NK cells from chronically infected viremic HCV patients 123
'Emergency exit' of bone-marrow-resident CD34+ DNAM-1 bright CXCR4+-committed lymphoid precursors during chronic infection and inflammation 122
Successfully treated HIV-infected patients have differential expression of NK cell receptors (NKp46 and NKp30) according to AIDS status at presentation. 120
Empirical first-line treatment with tigecycline for febrile episodes following abdominal surgery in cancer patients 119
Adhesion of human neuroblasts to HIV-1 tat. 119
Relationship between innate immunity, soluble markers and metabolic-clinical parameters in HIV+ patients ART treated with HIV-RNA < 50 cp/mL 119
Activating NK cell receptor expression/function (NKp30, NKp46, DNAM-1) during chronic viraemic HCV infection is associated with the outcome of combined treatment. 118
Clinically stable treatment-experienced adults receiving tenofovir and didanosine. 117
Analysis of NK cell function and receptor expression during HTLV-1 and HTLV-2 infection 117
Late symptomatic neurosyphilis presenting as a motor polyradiculoneuropathy. 116
HLA-class I-specific inhibitory receptors in HIV-1 infection. 114
Children born to women with HIV-1 infection: natural history and risk of transmission 114
Clinical and Microbiological Characterization of Late Breast Implant Infections after Reconstructive Breast Cancer Surgery 114
Benserazide effects on growth hormone, prolactin, and thyrotropin in normal and acromegalic man. 113
Early active tuberculosis in gold miners who undergo HIV seroconversion: should it influence general practice? 112
NK cell receptors and their interactions with MHC. 112
Effects on growth after switching protease inhibitors to efavirenz in HIV-1-infected children 111
null 111
HIV-1 viral load and CD4 cell count in untreated children with vertically acquired asymptomatic or mild disease. 111
HTLV-1/-2 and HIV-1 co-infections: retroviral interference on host immune status. 111
Low expression of inhibitory natural killer receptors in CD8 cytotoxic T lymphocytes in long-term non-progressor HIV-1-infected patients 111
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 111
Levels and patterns of neutrophil cell counts over the first 8 years of life in children of HIV-1-infected mothers. 110
Detection of virus in vertically exposed HIV-antibody-negative children. 109
Revisited function of human NK cell subsets. 109
Perinatal findings in children born to HIV-infected mothers 109
Insufficient antiretroviral therapy in pregnancy: missed opportunities for prevention of mother-to- child transmission of HIV in Europe 109
Accuracy of HCV-RNA PCR tests for diagnosis or exclusion of vertically acquired HCV infection. 109
May immunization strategies that target dendritic cells really offer advantages for HIV-1? 109
Inherent transcriptional signatures of NK cells are associated with response to IFNΑ+rivabirin therapy in patients with Hepatitis C Virus 109
Chemotherapy Mass Campaigns and Migratory Flows: An Unexpected Connection 109
Transfer of HIV-1 to human tonsillar stromal cells following cocultivation with infected lymphocytes. 109
An Historical Overview: The Discovery of How NK Cells Can Kill Enemies, Recruit Defense Troops, and More 109
Pre-filled normal saline syringes to reduce totally implantable venous access device-associated bloodstream infection: a single institution pilot study. 108
Detection of CD8 T-cell expansions with restricted T-cell receptor V gene usage in infants vertically infected by HIV-1. 108
Unsung hero Robert C. Gallo 108
Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy. 107
NK cell function in HIV-1 infection 107
Low incidence of congenital toxoplasmosis in children born to women infected with human immunodeficiency virus 107
Popolazione di precursori linfoidi umani, metodo per la loro identificazione e relativi usi 107
Inhaled triamcinolone and chronic obstructive pulmonary disease. 107
Whole blood collection on filter paper is an effective means of obtaining samples for human immunodeficiency virus antibody assay. 106
Absence of HIV-1 after treatment cessation in an infant. 106
Minocycline for symptomatic neurosyphilis in patients allergic to penicillin. 105
Improvements in virological control among women conceiving on combination antiretroviral therapy in Western Europe. 105
Important factors to consider for patients with community-acquired pneumonia 105
Increasing likelihood of further live births in HIV-infected women in recent years. 105
Rete Ligure dell’HIV: due anni di esperienza nella gestione del dato clinico 105
Conserved T cell and natural killer cell function in treatment-experienced adults receiving tenofovir plus didanosine reverse transcription inhibitor backbone 104
Changes in the dopaminergic control of prolactin secretion and in ovarian steroids in migraine. 104
Risk factors for mother-to-child transmission of HIV-1. 104
Possible hepatitis C virus involvement in acute meningoradiculitis/polyradiculitis of HIV-1-co-infected patients. 104
Baseline and Dynamic Expression of Activating NK Cell Receptors in the Control of Chronic Viral Infections: The Paradigm of HIV-1 and HCV. 104
Significant NK cell activation associated with decreased cytolytic function in peripheral blood of HIV-1 infected patients 103
NK-cell phenotype at interruption underlies widely divergent duration of CD4+-guided antiretroviral treatment interruption. 103
Impact of a mixed educational and semi-restrictive antimicrobial stewardship project in a large teaching hospital in Northern Italy 103
Time to undetectable viral load after highly active antiretroviral therapy initiation among HIV-infected pregnant women. 103
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 103
Levels and patterns of HIV RNA viral load in untreated pregnant women. 103
Fluctuations in symptoms in human immunodeficiency virus-infected children: the first 10 years of life. 102
CD4saurus Rex &HIVelociraptor vs. development of clinically useful immunological markers: a Jurassic tale of frozen evolution. 102
Characteristics of pregnant HIV-1 infected women in Europe 102
Pregnancies in young women with vertically acquired HIV infection in Europe. 102
Modulation of CD112 by the alphaherpesvirus gD protein suppresses DNAM-1-dependent NK cell-mediated lysis of infected cells. 102
Management of fever in children: summary of the Italian Pediatric Society guidelines. 102
Routine vaccination and vaccine-preventable infections in children born to human immunodeficiency virus-infected mothers. 102
Neuropsychological deficits in neuroborreliosis. 101
Use of maraviroc in clinical practice: a multicenter observational study 101
Breast Implant Infections after Surgical Reconstruction in Patients with Breast Cancer: Assessment of Risk Factors and Pathogens over Extended Post-Operative Observation. 101
Intraperitoneal infusion of interleukin-2 in patients with malignant ascites: phenotypic and functional effects on tumor-associated lymphocytes. 101
Receptor modulation and functional activation of human CD34(+) Lin(-) -derived immature NK-cells in vitro by Mycobacterium Bovis Calmette-Guerin (BCG). 101
The MHC class II transactivator: prey and hunter in infectious diseases. 100
Use of polymerase chain reaction and quantitative antibody tests in children born to human immunodeficiency virus-1-infected mothers. 100
Patients Treated with Rituximab-Containing Immunochemotherapy Have a Significant and Prolonged Lack of Humoral Response to Influenza Vaccine Associated with a Persistent Depletion of B Memory Cells 100
Does exposure to antiretroviral therapy affect growth in the first 18 months of life in uninfected children born to HIV-infected women? 100
Unusual presentation of visceral leishmaniasis in an HIV-infected patient. 100
HIV serological screening in a population of pregnant women in the Republic of Congo: suitability of different assays 99
Breast implant infection due to Paenibacillus residui in a cancer patient 99
Differential NKp30 inducibility in chimpanzee NK cells and conserved NK cell phenotype and function in long-term HIV-1-infected animals 99
Maternal and infant factors and lymphocyte, CD4 and CD8 cell counts in uninfected children of HIV-1-infected mothers. 99
The European Collaborative Study: clinical and immunological characteristics of HIV 1-infected pregnant women. 98
Varied spectrum of clinical presentation and mortality in a prospective registry of visceral leishmaniasis in a low endemicity area of Northern Italy. 97
Totale 11.232
Categoria #
all - tutte 57.246
article - articoli 52.047
book - libri 171
conference - conferenze 788
curatela - curatele 0
other - altro 0
patent - brevetti 561
selected - selezionate 0
volume - volumi 3.679
Totale 114.492


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.010 0 0 0 0 0 0 0 0 0 0 555 455
2019/20206.241 235 144 301 347 575 696 983 384 531 1.104 707 234
2020/20211.674 104 163 98 125 147 179 104 148 166 185 128 127
2021/20223.017 73 185 193 360 150 278 160 722 135 308 77 376
2022/20233.247 333 195 43 300 474 633 30 233 522 99 332 53
2023/20241.153 75 247 37 141 116 229 49 111 99 47 2 0
Totale 22.552